BioStock covered the leadership transition at Sigrid Therapeutics as Claus Kjærsgaard was appointed Chief Executive Officer, with a new management focus on scaling the company commercially.
Media Coverage
Sigrid Therapeutics utser Claus Kjærsgaard till ny VD
Media: BioStock
Featuring: Claus Kjærsgaard
BioStock reports on the appointment of Claus Kjærsgaard as the new CEO of Sigrid Therapeutics.
LeadershipCEO appointment


